Patrick Truesdell - Net Worth and Insider Trading

Patrick Truesdell Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Patrick Truesdell owns 1 companies in total, including Landos Biopharma Inc (LABP) .

Click here to see the complete history of Patrick Truesdell’s form 4 insider trades.

Insider Ownership Summary of Patrick Truesdell

Ticker Comapny Transaction Date Type of Owner
LABP Landos Biopharma Inc 2022-05-16 Vice President and Controller

Patrick Truesdell Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Patrick Truesdell Ownership Network

Ownership Network List of Patrick Truesdell

No Data

Ownership Network Relation of Patrick Truesdell

Insider Network Chart

Patrick Truesdell Owned Company Details

What does Landos Biopharma Inc do?

Who are the key executives at Landos Biopharma Inc?

Patrick Truesdell is the Vice President and Controller of Landos Biopharma Inc. Other key executives at Landos Biopharma Inc include 10 percent owner Perceptive Xontogeny Venture Fund Ii, Lp , 10 percent owner Roderick Wong , and 10 percent owner Rtw Investments, Lp .

Landos Biopharma Inc (LABP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Landos Biopharma Inc (LABP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Landos Biopharma Inc (LABP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Landos Biopharma Inc (LABP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Landos Biopharma Inc Insider Transactions

No Available Data

Patrick Truesdell Mailing Address

Above is the net worth, insider trading, and ownership report for Patrick Truesdell. You might contact Patrick Truesdell via mailing address: C/o Landos Biopharma, Inc., 1800 Kraft Drive, Suite 216, Blackburg Va 24060.

Discussions on Patrick Truesdell

No discussions yet.